Answer Choices:
Coagulation studies
🩺Baseline coagulation studies (especially activated partial thromboplastin time) are required to determine the starting dose and monitor the therapeutic effect of heparin.
⏳Heparin’s primary action is to prolong clotting time, so knowing the client’s baseline clotting status prevents overdosing or underdosing.
📊Periodic coagulation monitoring ensures the aPTT remains within the therapeutic range, reducing the risk of bleeding or thrombosis.
🩸While a CBC is important for platelet counts, the immediate priority is to assess clotting function before heparin administration.
📌Core Message
Obtain baseline coagulation studies to safely initiate heparin therapy.
This question is from NCLEX RN-Readiness Assessment Test-2 which contains 106 questions.
Answer Choices:
Answer Choices:
Answer Choices:
Answer Choices:
Answer Choices: